Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/05/24
Country: United States
Summary: Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab) is designed to to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.https://www.creative-biolabs.com/bsab/symbolsearch-baff%2520%2526%2520il17.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
